Table 1.
Characteristic
|
All (n = 371)
|
Sex, n (%) | |
Male | 247 (66.6) |
Female | 124 (33.4) |
Age, yr | 39.86 ± 10.20 |
BMI (kg/m2) | 25.99 ± 3.18 |
Causes, n (%) | 203 (54.7) |
Diet (high fatty acid) | 127 (34.2) |
Drinking (beer) | 55 (14.8) |
Mixed | 21 (5.7) |
Complications, n (%) | |
Diabetes mellitus | 115 (31.0) |
Hypertension | 62 (16.7) |
Fatty liver disease | 336 (90.6) |
Pregnancy | 11 (3.0) |
Recurrence, n (%) | 122 (32.9) |
Grades of severity, n (%) | |
MAP | 63 (17.0) |
MSAP | 208 (56.1) |
SAP | 100 (26.9) |
Improved Marshall score | 1.30 ± 1.77 |
Organ failure, n (%) | 117 (31.5) |
MCTSI score | 5.00 ± 1.83 |
Lipid-lowering treatment, n (%) | |
Intravenous insulin | 144 (38.8) |
HP | 32 (8.6) |
CRRT/HP + CRRT | 77 (20.8) |
Only anti-lipemic | 118 (31.8) |
Baseline TG, mg/dL | 2544.59 ± 2305.37 |
Baseline AMY (nUNL) | 5.00 ± 6.47 |
> UNL, n (%) | 297 (80.1) |
≥ 3UNL, n (%) | 174 (46.9) |
Admission to ICU, n (%) | 126 (34.0) |
Death, n (%) | 11 (3.0) |
BMI: Body mass index; MAP: Mild acute pancreatitis; MSAP: Moderately severe acute pancreatitis; SAP: Severe acute pancreatitis; MCTSI: Modified computed tomography severity index; HP: Hemoperfusion; CRRT: Continuous renal replacement therapy; TG: Triglyceride; AMY: Amylase; UNL: Upper limit of normal; ICU: Intensive care unit.